Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 109671601000001117 | Atovaquone 750mg/5ml oral suspension sugar free (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 109671701000001110 | Atovaquone 750mg/5ml oral suspension sugar free | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Atovaquone 750mg/5ml oral suspension sugar free | Is a | Product containing atovaquone | false | Inferred relationship | Existential restriction modifier | ||
| Atovaquone 750mg/5ml oral suspension sugar free | Has active ingredient | Atovaquone | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Atovaquone 750mg/5ml oral suspension sugar free 226 ml | Has VMP | False | Atovaquone 750mg/5ml oral suspension sugar free | Inferred relationship | Existential restriction modifier | |
| Atovaquone 750mg/5ml oral suspension sugar free 210 ml | Has VMP | False | Atovaquone 750mg/5ml oral suspension sugar free | Inferred relationship | Existential restriction modifier | |
| Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) | Is a | False | Atovaquone 750mg/5ml oral suspension sugar free | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR